Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Q4 Print
Tweet Send to a Friend
Benchmark analyst Robert Wasserman reiterated a Speculative Buy rating and $6.00 price target on Nephros (NASDAQ: NEPH).The analyst commented, "Nephros ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
